GlassScriptPhysician profile
Timothy A Glass
NPI 1477552057
$1,468.63
in general payments reported to CMS, 2019-2025
15 companies · $556 in 2025
The $556 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $67.68 · 2021: $104 · 2022: $94.98 · 2023: $284 · 2024: $172 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $359.21 | 2019-2025 | |
| Tela Bio, INC. | $309.80 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Aroa Biosurgery Incorporated | $236.29 | 2022-2025 | |
| Acell, INC. | $142.10 | 2019 | |
| Kerecis Limited | $80.36 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $75.98 | 2023-2025 | Gattex |
| Medtronic, INC. | $67.51 | 2022-2024 | Progrip |
| Teleflex LLC | $35.24 | 2021 | |
| Convatec INC. | $33.04 | 2024 | |
| Integra Lifesciences Corporation | $31.14 | 2021 | |
| W. L. Gore & Associates, INC. | $26.75 | 2022 | |
| Baxter Healthcare | $22.73 | 2021 | |
| Karl Storz Endoscopy-America | $19.30 | 2023 | Image1 X-Link |
| Sanara Medtech INC. | $14.68 | 2021 | |
| Novo Nordisk INC | $14.50 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Glass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.